Table 2.
Smoking status and cardiac structure and function assessed by CMR at Visit 3
Model 1 |
Model 2 |
|||||
---|---|---|---|---|---|---|
Never Smoker (n=791) |
Former Smoker (n=198) |
Current Smoker (N=103) |
Never Smoker (n=791) |
Former Smoker (n=198) |
Current Smoker (n=103) |
|
Variable | β (95%CI) | β (95%CI) | β (95%CI) | β (95%CI) | ||
LVEDVI, ml/m2 | Ref. | −22.27 (−4.55, 0.14) | −1.86 (−4.81, 1.08) | Ref. | −2.09 (−4.36, 0.18) | −2.35 (−5.29, 0.60) |
LVESVI, ml/2 | Ref. | −1.06 (−2.55, 0.43) | 0.12 (−1.80, 2.05) | Ref. | −1.02 (−1.92, 1.94) | 0.01 (−1.92, 1.94) |
SVI, ml/2 | Ref. | −1.21 (−2.68, 0.25) | −1.99 (−3.88, 0.10) | Ref. | −1.07 (−2.53, 0.39) | −2.35 (−4.24, −0.47) |
LVEF, % | Ref. | 0.01 (−1.41, 1.43) | −0.75 (−2.58, 1.08) | Ref. | 0.09 (−1.33, 1.51) | −0.82 (−2.66, 1.02) |
LVMI, g/m2 | Ref. | −2.09 (−4.21, 0.02) | 4.97 (2.24, 7.69) † | Ref. | −1.73 (−3.69, 0.22) | 5.24 (2.71, 7.77) † |
LV mass / volume | Ref. | 0.01 (−0.04, 0.06) | 0.10 (0.04, 0.17) † | Ref. | 0.01 (−0.03, 0.06) | 0.12 (0.06, 0.18) † |
LV Strain# | ||||||
Total Strain, % | Ref. | 0.02 (−0.36, 0.41) | 0.56 (0.07, 1.06) * | Ref. | 0.01 (−0.37, 0.38) | 0.74 (0.26, 1.22) † |
Base Strain, % | Ref. | 0.08 (−0.39, 0.55) | 0.60 (−0.01, 1.20) | Ref. | 0.08 (−0.38, 0.55) | 0.71 (0.12, 1.31) * |
Mid Strain, % | Ref. | −0.13 (−0.63, 0.38) | 0.50 (−0.15, 1.15) | Ref. | −0.16 (−0.66, 0.33) | 0.71 (0.07, 1.34) * |
Apex Strain, % | Ref. | 0.16 (−0.31, 0.63) | 0.61 (0.01, 1.21) * | Ref. | 0.14 (−0.32, 0.59) | 0.82 (0.23, 1.41) † |
PWV, m/sec | Ref. | 0.23 (−0.65, 1.12) | 1.42 (0.27, 2.57) * | Ref. | 0.24 (−0.64, 1.12) | 1.25 (0.09, 2.41) * |
LVEDV: left ventricular end-diastolic volume, LVEF: left ventricular ejection fraction, LVESV: left ventricular end-systolic volume, LVMI: left ventricular mass index, PWV: pulse wave velocity from ascending aorta to descending aorta. #: Strain indicators represent mean peak systolic circumferential strain. Visit 3 smoking status information was used for the analysis. Model 1: adjusted for age and sex. Model 2: further adjusted for systolic blood pressure, anti-hypertensive medication use, body mass index, diabetes, and estimated glomerular filtration rate.
p<0.05
p<0.01.